Antiviral activity of WIN 54954 in coxsackievirus B2 carrier state infected human myocardial fibroblasts.
about
Immunomodulatory treatment strategies in inflammatory cardiomyopathy: current status and future perspectives.Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection.Antitumor Potential of Acyclic Nucleoside Phosphonates
P2860
Antiviral activity of WIN 54954 in coxsackievirus B2 carrier state infected human myocardial fibroblasts.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Antiviral activity of WIN 5495 ...... human myocardial fibroblasts.
@en
Antiviral activity of WIN 5495 ...... human myocardial fibroblasts.
@nl
type
label
Antiviral activity of WIN 5495 ...... human myocardial fibroblasts.
@en
Antiviral activity of WIN 5495 ...... human myocardial fibroblasts.
@nl
prefLabel
Antiviral activity of WIN 5495 ...... human myocardial fibroblasts.
@en
Antiviral activity of WIN 5495 ...... human myocardial fibroblasts.
@nl
P1433
P1476
Antiviral activity of WIN 5495 ...... d human myocardial fibroblasts
@en
P2093
P356
10.1016/S0166-3542(97)00056-9
P577
1998-01-01T00:00:00Z